XML 64 R53.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders' Equity - Schedule of Restricted Stock and Contingent restricted Stock (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Jun. 30, 2022
Number of Restricted Shares      
Granted (in shares) 100,000 200,000  
Unvested, end of period (in shares) 403,854    
Weighted Average Grant-Date Fair Value      
Unvested, end of period (in USD per share) $ 5.15    
Restricted Stock      
Number of Restricted Shares      
Unvested, beginning of period (in shares) 341,211    
Vested (in shares) (16,688)    
Unvested, end of period (in shares) 403,854   341,211
Weighted Average Grant-Date Fair Value      
Unvested, beginning of period (in USD per share) $ 4.54    
Vested (in USD per share) 3.89    
Unvested, end of period (in USD per share) $ 5.15   $ 4.54
Unamortized compensation expense $ 1,485   $ 1,092
Weighted Average Remaining Amortization Period (Years) 2 years 1 month 6 days   2 years 1 month 6 days
Restricted Stock, Performance Based      
Number of Restricted Shares      
Granted (in shares) 44,381 100,000  
Unvested, end of period (in shares) 144,503    
Weighted Average Grant-Date Fair Value      
Granted (in USD per share) $ 7.61    
Unvested, end of period (in USD per share) $ 4.55    
Restricted Stock Time Vested      
Number of Restricted Shares      
Granted (in shares) 34,950 100,000  
Unvested, end of period (in shares) 259,351    
Weighted Average Grant-Date Fair Value      
Granted (in USD per share) $ 7.38    
Unvested, end of period (in USD per share) $ 5.49    
Contingent Restricted Stock Grants      
Number of Restricted Shares      
Unvested, beginning of period (in shares) 50,062    
Unvested, end of period (in shares) 72,255   50,062
Weighted Average Grant-Date Fair Value      
Unvested, beginning of period (in USD per share) $ 2.21    
Unvested, end of period (in USD per share) $ 3.11   $ 2.21
Unamortized compensation expense $ 169   $ 68
Weighted Average Remaining Amortization Period (Years) 2 years 3 months 18 days   1 year 8 months 12 days
Performance Based Contingent Shares      
Number of Restricted Shares      
Granted (in shares) 22,193    
Weighted Average Grant-Date Fair Value      
Granted (in USD per share) $ 5.13